Resources
We play an active role in breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.
Our team produces media releases, reports, policy papers and other informative content to keep you up to date on the most pressing issues facing our industry. Here in our resources section, you’ll find our most recent work.
ANALYSIS & REPORTS
Cost Drivers Report 2024: Analysis of Private Drug Plan Trends in Canada
For the second year in a row,
we saw considerable growth
in the number of claimants
with an 8.5% increase, making
it the main driver of overall
cost. This increase in claimants
was balanced by a low single
digit increase in the cost per
claimants of 2.7%. Read the full report.
RESEARCH
Cost Drivers Report 2024: Analysis of Private Drug Plan Trends in Canada
For the second year in a row,
we saw considerable growth
in the number of claimants
with an 8.5% increase, making
it the main driver of overall
cost. This increase in claimants
was balanced by a low single
digit increase in the cost per
claimants of 2.7%. Read the full report.
Bluesky Project
Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022
INFOGRAPHICS & DATA
Two years is too long – Understanding Canada’s Drug Access Pathway
Canadians wait two years for access to new medicines through our public drug plans. That’s a full year longer than patients in most other peer countries. Two years can feel like a lifetime for a patient waiting for access to life-saving medicines or treatments.
Better Access Better Health
More than 23-million Canadians depend on access to medicines and vaccines through employer-sponsored private plans.
RELATED LINKS
Search for Specific Brand Name Drug Negotiations Status with the pCPA
Use this tool to search for brand name drugs to view their current negotiation status.
pCPA overview of the Negotiation Process
Learn more about the negotiation process from the pCPA.
Canadian Public Reimbursement Timelines
One of Innovative Medicines Canada’s guiding principles is to offer solutions to challenges in the Canadian health system. Access to new medicines is one such challenge.
Pharma 101
Use this beginner’s guide to understand the basics of how our industry works.
Advocacy
Everything you need to make an informed decision about our industry.
Newsroom
Breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.
